Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy

Cancer immunotherapy, especially immune checkpoint therapy, has revolutionized therapeutic options by reactivating the host immune system. However, the efficacy varies, and only a small portion of patients dev...

Source: Molecular Cancer - February 21, 2023 Category: Cancer & Oncology Authors: Xianyong Zhou, Chen Li, Tong Chen, Wenhao Li, Xiaolong Wang and Qifeng Yang Tags: Review Source Type: research